Glaxo’s Buyout of Cancer Drugmaker Tesaro Seen as Too Expensive

GlaxoSmithKline Plc Chief Executive Officer Emma Walmsley bolstered a thin roster of new treatments by agreeing to buy drugmaker Tesaro Inc. for $5.1 billion, gaining a foothold in the field of cancer for a price analysts deemed high. After announcing a deal to pay $75 a share for Tesaro, about 62 percent more than the…

Now, a Test to Detect Cancer & HIV with Naked Eye

Scientists have developed a new ten times cheaper ultra-sensitive sensor test to detect the early stages of several cancers and viruses, including HIV, with the naked eye. Researchers from the Imperial College London claim that their visual sensor technology is ten times more sensitive than the current gold standard methods for measuring biomarkers. These indicate…